Literature DB >> 20010879

Determinants of kidney dysfunction: is vasopressin a new player in the arena?

Massimo Cirillo.   

Abstract

Copeptin is a marker of endogenous vasopressin secretion. Population-based data of the PREVEND Study show that men and women with high plasma copeptin have a highly prevalent microalbuminuria in addition to the low level of hydration typical of persons with high vasopressin secretion. The association of plasma copeptin with microalbuminuria suggests that vasopressin might have a role in kidney dysfunction via effects on the permselectivity of the glomerulus and/or on tubular albumin reabsorption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20010879     DOI: 10.1038/ki.2009.408

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Validation of Surrogates of Urine Osmolality in Population Studies.

Authors:  Sonia Youhanna; Lise Bankir; Paul Jungers; David Porteous; Ozren Polasek; Murielle Bochud; Caroline Hayward; Olivier Devuyst
Journal:  Am J Nephrol       Date:  2017-06-07       Impact factor: 3.754

2.  Hydration and kidney health.

Authors:  Nadine Bouby; William F Clark; Ronan Roussel; Christopher Taveau; Connie J Wang
Journal:  Obes Facts       Date:  2014-04-04       Impact factor: 3.942

3.  Sodium Intake and Proteinuria/Albuminuria in the Population-Observational, Cross-Sectional Study.

Authors:  Massimo Cirillo; Pierpaolo Cavallo; Enrico Zulli; Rachele Villa; Rosangela Veneziano; Simona Costanzo; Sara Magnacca; Augusto Di Castelnuovo; Licia Iacoviello
Journal:  Nutrients       Date:  2021-04-11       Impact factor: 5.717

4.  The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trial.

Authors:  William F Clark; Jessica M Sontrop; Shih-Han Huang; Kerri Gallo; Louise Moist; Andrew A House; Matthew A Weir; Amit X Garg
Journal:  BMJ Open       Date:  2013-12-20       Impact factor: 2.692

5.  Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial.

Authors:  Jessica M Sontrop; Shi-Han Huang; Amit X Garg; Louise Moist; Andrew A House; Kerri Gallo; William F Clark
Journal:  BMJ Open       Date:  2015-11-24       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.